4.6 Review

Effect of vitamin C on endothelial function in health and disease: A systematic review and meta-analysis of randomised controlled trials

期刊

ATHEROSCLEROSIS
卷 235, 期 1, 页码 9-20

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2014.04.004

关键词

Ascorbic acid; Flow-mediated dilation; Forearm blood flow; Nutritional supplements; Cardiovascular risk

资金

  1. Ministry of Higher Education and Scientific Research of Iraq
  2. Live-Well Programme a research project funded through a collaborative grant from the Lifelong Health and Wellbeing (LLHW) initiative
  3. Biotechnology and Biological Sciences Research Council
  4. Engineering and Physical Sciences Research Council
  5. Economic and Social Research Council
  6. Medical Research Council
  7. Chief Scientist Office of the Scottish Government Health Directorates
  8. National Institute for Health Research (NIHR) The Department of Health
  9. Health and Social Care Research & Development of the Public Health Agency (Northern Ireland)
  10. Wales Office of Research and Development for Health and Social Care
  11. Welsh Assembly Government [G0900686]
  12. Medical Research Council [G0900686, G0700718, MR/K006312/1] Funding Source: researchfish
  13. NIHR Newcastle Biomedical Research Centre [BH111030] Funding Source: researchfish
  14. MRC [MR/K006312/1, G0900686, G0700718] Funding Source: UKRI

向作者/读者索取更多资源

Background: Observational studies indicate that higher vitamin C intake is associated with reduced risk for cardiovascular diseases. However, randomised controlled trials (RCT) examining the effect of vitamin C on endothelial function (EF) have reported inconsistent results. The aims of this systematic review and meta-analysis were to determine the effect of vitamin C supplementation on EF and to investigate whether the effect was influenced by health status, study duration, dose and route of vitamin C administration. Methods: We searched the Medline, Embase, Cochrane Library, and Scopus databases from inception to May 2013 for studies that met the following criteria: 1) RCT with adult participants, 2) vitamin C administered alone, 3) studies that quantified EF using commonly applied methods including ultrasound, plethysmography and pulse wave analysis. Results: Pooling the data from 44 clinical trials showed a significant positive effect of vitamin C on EF (SMD: 0.50, 95% CI: 0.34, 0.66, P < 0.001). Stratification of the analysis by health outcome revealed improved EF in atherosclerotic (SMD: 0.84, 95% CI: 0.41, 1.26, P < 0.001), diabetic (SMD: 0.52, 95% CI: 0.21, 0.82, P < 0.001) and heart failure patients (SMD: 0.48, 95% CI: 0.08, 0.88, P < 0.02) after vitamin C supplementation. The effect size appeared to be unaffected by study design, duration, baseline plasma vitamin C concentration or route of administration of vitamin C. The meta-regression showed a significant positive association between vitamin C dose and improvement in EF (beta: 0.00011, 95% CI: 0.00001, 0.00021, P = 0.03). Conclusions: Vitamin C supplementation improved EF. The effect of vitamin C supplementation appeared to be dependent on health status, with stronger effects in those at higher cardiovascular disease risk. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据